$39.99
-1.86-4.44%
At close: Nov 11, 4:00 PM EST
$40.01
-1.84-4.4%
Pre-Market: 8:05 AM EST
Roivant Sciences Ltd
ROIVNASDAQ
Roivant Sciences rose 94.5% from $20.56 to $39.99, ahead of the S&P 500's +12.7%. Its worst day was Aug 28 (−7.6%), and its low came Nov 21 at $20.22.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Roivant Sciences closed at its lowest level of the year, 1.7% below where the year started.
−0.2% · S&P 500 +1.0%
EPS of $-0.24 beat the $-0.34 estimate on $2.0M revenue (est. $6.1M).
Story events cover the past 12 months · Times ET
+22.1%, the year's best day · S&P 500 +1.9%
EPS of $-0.27 beat the $-0.36 estimate on $2.5M revenue (est. $3.7M).
+14.9% · S&P 500 +1.0%
EPS of $-0.34 beat the $-0.37 estimate on $1.4M revenue (est. $2.3M).
+1.5% · S&P 500 −0.2%
Roivant Sciences shares fell 7.6%, while the S&P 500 fell 0.2%.
−7.6%, the year's worst day · S&P 500 −0.2%
Roivant Sciences shares rose 18.8%, while the S&P 500 fell 0.5%.
+18.8% · S&P 500 −0.5%
EPS of $-0.27 beat the $-0.46 estimate on $35.1M revenue (est. $3.8M).
+4.6% · S&P 500 +2.4%
Where it ended: a close of $39.99 on Nov 12, 2026. Up next: Q3 2027 earnings on Feb 5, 2027 (EPS est. $-0.42, revenue est. $48.2M).
Nothing in the past 12 months.
All ROIV dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ROIV and SPY from Benzinga historical bars. Not investment advice.
